Patents by Inventor Lloyd Waxman

Lloyd Waxman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inhibiting hepatitis c virus processing and replication
    Publication number: 20030211469
    Abstract: The present invention features methods for inhibiting HCV replication and processing by targeting heat shock protein 90 (HSP90). HSP90 is a cellular chaperone protein that was found to be an essential factor in NS2/3 self-cleavage. HSP90 can be targeted using compounds inhibiting the ability of HSP90 to facilitate NS2/3 cleavage.
    Type: Application
    Filed: January 17, 2003
    Publication date: November 13, 2003
    Inventor: Lloyd Waxman
  • Proteins for inhibiting adhesion of platelets to collagen
    Patent number: 5321010
    Abstract: The invention comprises proteinaceous substances isolated from crude Ornithodoros moubata extract which inhibit adhesion of platelets to collagen. These substances do not inhibit platelet adhesion to fibrinogen, and are therefore particularly useful for inhibiting adhesion of platelets to collagen when simultaneous inhibition of platelet adhesion to fibrinogen is undesired. They are particularly useful in the prevention, prophylaxis, therapy and treatment of thrombotic diseases.
    Type: Grant
    Filed: December 10, 1991
    Date of Patent: June 14, 1994
    Assignee: Merck & Co., Inc.
    Inventors: Thomas M. Connolly, Michael Neeper, Lloyd Waxman